CJD (Creutzfeldt-Jakob Disease) Quinacrine Study

Clinical trial NCT00183092 · COMPLETED

Trial details

NCT number: NCT00183092
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Creutzfeldt-Jakob Disease

Start date: 2005-04-01
Primary completion: 2012-06-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.